Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. / Sveen, Marie-Louise; Thune, Jens Jakob; Køber, Lars; Vissing, John.

I: Archives of Neurology, Bind 65, Nr. 9, 2008, s. 1196-201.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sveen, M-L, Thune, JJ, Køber, L & Vissing, J 2008, 'Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy', Archives of Neurology, bind 65, nr. 9, s. 1196-201. https://doi.org/10.1001/archneur.65.9.1196

APA

Sveen, M-L., Thune, J. J., Køber, L., & Vissing, J. (2008). Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Archives of Neurology, 65(9), 1196-201. https://doi.org/10.1001/archneur.65.9.1196

Vancouver

Sveen M-L, Thune JJ, Køber L, Vissing J. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Archives of Neurology. 2008;65(9):1196-201. https://doi.org/10.1001/archneur.65.9.1196

Author

Sveen, Marie-Louise ; Thune, Jens Jakob ; Køber, Lars ; Vissing, John. / Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. I: Archives of Neurology. 2008 ; Bind 65, Nr. 9. s. 1196-201.

Bibtex

@article{23e8c3a0117f11df803f000ea68e967b,
title = "Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy",
abstract = "OBJECTIVE: To investigate the extent of cardiac involvement in patients with 1 of the 12 groups of recessively inherited limb-girdle muscular dystrophy type 2 (LGMD2A-L) and Becker muscular dystrophy (BMD). DESIGN: Prospective screening. SETTING: Neuromuscular Clinic and Department of Cardiology at Rigshospitalet. Patients One hundred one patients with LGMD2A-I and BMD and 29 patients with LGMD2 and no molecular diagnosis. MAIN OUTCOME MEASURES: Clinical investigation, echocardiography, and electrocardiographic findings. RESULTS: Cardiac involvement was present in 24 of 100 patients (24%) with LGMD2A-I and in 14 of 30 patients (47%) with BMD. Only a few patients with LGMD2A and unclassified LGMD2 had mild cardiac involvement, whereas 29% and 67% of patients with LGMD2I and LGMD2E, respectively, had cardiac involvement. Cardiac involvement was not correlated with age, muscle strength, or the level of dystrophic changes on muscle biopsy. CONCLUSIONS: This study demonstrates a high prevalence of cardiac involvement in patients with LGMD2I, LGMD2E, and BMD. Patients with LGMD2A, LGMD2D, and unclassified LGMD2 have a much lower and milder prevalence of cardiac involvement.",
author = "Marie-Louise Sveen and Thune, {Jens Jakob} and Lars K{\o}ber and John Vissing",
note = "Keywords: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Prospective Studies",
year = "2008",
doi = "10.1001/archneur.65.9.1196",
language = "English",
volume = "65",
pages = "1196--201",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "The JAMA Network",
number = "9",

}

RIS

TY - JOUR

T1 - Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy

AU - Sveen, Marie-Louise

AU - Thune, Jens Jakob

AU - Køber, Lars

AU - Vissing, John

N1 - Keywords: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Prospective Studies

PY - 2008

Y1 - 2008

N2 - OBJECTIVE: To investigate the extent of cardiac involvement in patients with 1 of the 12 groups of recessively inherited limb-girdle muscular dystrophy type 2 (LGMD2A-L) and Becker muscular dystrophy (BMD). DESIGN: Prospective screening. SETTING: Neuromuscular Clinic and Department of Cardiology at Rigshospitalet. Patients One hundred one patients with LGMD2A-I and BMD and 29 patients with LGMD2 and no molecular diagnosis. MAIN OUTCOME MEASURES: Clinical investigation, echocardiography, and electrocardiographic findings. RESULTS: Cardiac involvement was present in 24 of 100 patients (24%) with LGMD2A-I and in 14 of 30 patients (47%) with BMD. Only a few patients with LGMD2A and unclassified LGMD2 had mild cardiac involvement, whereas 29% and 67% of patients with LGMD2I and LGMD2E, respectively, had cardiac involvement. Cardiac involvement was not correlated with age, muscle strength, or the level of dystrophic changes on muscle biopsy. CONCLUSIONS: This study demonstrates a high prevalence of cardiac involvement in patients with LGMD2I, LGMD2E, and BMD. Patients with LGMD2A, LGMD2D, and unclassified LGMD2 have a much lower and milder prevalence of cardiac involvement.

AB - OBJECTIVE: To investigate the extent of cardiac involvement in patients with 1 of the 12 groups of recessively inherited limb-girdle muscular dystrophy type 2 (LGMD2A-L) and Becker muscular dystrophy (BMD). DESIGN: Prospective screening. SETTING: Neuromuscular Clinic and Department of Cardiology at Rigshospitalet. Patients One hundred one patients with LGMD2A-I and BMD and 29 patients with LGMD2 and no molecular diagnosis. MAIN OUTCOME MEASURES: Clinical investigation, echocardiography, and electrocardiographic findings. RESULTS: Cardiac involvement was present in 24 of 100 patients (24%) with LGMD2A-I and in 14 of 30 patients (47%) with BMD. Only a few patients with LGMD2A and unclassified LGMD2 had mild cardiac involvement, whereas 29% and 67% of patients with LGMD2I and LGMD2E, respectively, had cardiac involvement. Cardiac involvement was not correlated with age, muscle strength, or the level of dystrophic changes on muscle biopsy. CONCLUSIONS: This study demonstrates a high prevalence of cardiac involvement in patients with LGMD2I, LGMD2E, and BMD. Patients with LGMD2A, LGMD2D, and unclassified LGMD2 have a much lower and milder prevalence of cardiac involvement.

U2 - 10.1001/archneur.65.9.1196

DO - 10.1001/archneur.65.9.1196

M3 - Journal article

C2 - 18779423

VL - 65

SP - 1196

EP - 1201

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 9

ER -

ID: 17395164